Literature DB >> 1639873

Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

T A McCaffrey1, D J Falcone, B Du.   

Abstract

Previous studies indicated that a major factor in heparin's ability to suppress the proliferation of vascular smooth muscle cells is an interaction with transforming growth factor-beta 1 (TGF-beta 1). Heparin appeared to bind directly to TGF-beta 1 and to prevent the association of TGF-beta 1 with alpha 2-macroglobulin (alpha 2-M). The present studies indicate that 20-70% of iodinated TGF-beta 1 binds to heparin-Sepharose and the retained fraction is eluted with approximately 0.37 M NaCl. Native, unlabelled platelet TGF-beta 1, however, is completely retained by heparin-Sepharose and eluted with 0.9-1.2 M NaCl. Using synthetic peptides, the regions of TGF-beta 1 that might be involved in the binding of heparin and other polyanions were examined. Sequence analysis of TGF-beta 1 indicated three regions with a high concentration of basic residues. Two of these regions had the basic residues arranged in a pattern homologous to reported consensus heparin-binding regions of other proteins. The third constituted a structurally novel pattern of basic residues. Synthetic peptides homologous to these three regions, but not to other regions of TGF-beta 1, were found to bind to heparin-Sepharose and were eluted with 0.15 M-0.30 M NaCl. Only two of these regions were capable of blocking the binding of heparin to 125I-TGF-beta. Immobilization of these peptides, followed by affinity purification of heparin, indicated that one peptide was capable of isolating subspecies of heparin with high and low affinity for authentic TGF-beta 1. The ability of TGF-beta 1 to bind to heparin or related proteoglycans under physiological conditions may be useful in understanding the biology of this pluripotent growth and metabolic signal. Conversely, a subspecies of heparin molecules with high affinity for TGF-beta 1 may be a factor in some of the diverse biological actions of heparin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639873     DOI: 10.1002/jcp.1041520226

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  45 in total

1.  Stimulation of Superficial Zone Protein/Lubricin/PRG4 by Transforming Growth Factor-β in Superficial Zone Articular Chondrocytes and Modulation by Glycosaminoglycans.

Authors:  Araceli Cuellar; A Hari Reddi
Journal:  Tissue Eng Part A       Date:  2014-12-23       Impact factor: 3.845

2.  Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.

Authors:  A Taniguchi; K Matsuzaki; K Nakano; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

Review 3.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

Review 4.  Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Authors:  Paul C Billings; Maurizio Pacifici
Journal:  Connect Tissue Res       Date:  2015       Impact factor: 3.417

5.  Injectable Peptide Decorated Functional Nanofibrous Hollow Microspheres to Direct Stem Cell Differentiation and Tissue Regeneration.

Authors:  Zhanpeng Zhang; Melanie J Gupte; Xiaobing Jin; Peter X Ma
Journal:  Adv Funct Mater       Date:  2015-01-21       Impact factor: 18.808

Review 6.  Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.

Authors:  Rajendra Gharbaran
Journal:  Tumour Biol       Date:  2016-06-18

Review 7.  Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.

Authors:  Charles W Frevert; Jessica Felgenhauer; Malgorzata Wygrecka; Madalina V Nastase; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

Review 8.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Authors:  A Schmitt-Gräff; A Desmoulière; G Gabbiani
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Regulation of smooth muscle cell growth by endothelium-derived factors.

Authors:  T Scott-Burden; P M Vanhoutte
Journal:  Tex Heart Inst J       Date:  1994

10.  VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro.

Authors:  Chetan Lakshmana Reddy; Nejla Yosef; Eroboghene E Ubogu
Journal:  Cell Mol Neurobiol       Date:  2013-05-26       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.